Checkpoint Therapeutics, Inc. Contracts & Agreements

70 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Executive Employment Agreement with Garrett Gray, effective as of January 7, 2025
Employment Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
2025
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2024
Form of Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2024
Form of Placement Agent Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2024
Form of Securities Purchase Agreement, dated as of July 2, 2024, by and between Checkpoint Therapeutics, Inc. and the Purchaser
Purchase Agreements
Checkpoint Therapeutics, Inc.
2024
Checkpoint Therapeutics, Inc. Amended and Restated 2015 Incentive Plan
Bonus & Incentive Agreements
Checkpoint Therapeutics, Inc.
2024
Amended and Restarted Non-Employee Directors Compensation Plan
Compensation Agreements
Checkpoint Therapeutics, Inc.
2024
Description of Securities of Checkpoint Therapeutics, Inc
Checkpoint Therapeutics, Inc.
2024
Mutual Termination Agreement (Sublicense) by and between Checkpoint Therapeutics, Inc. and TG Therapeutics, Inc. dated September 30, 2023
Termination Agreements
Checkpoint Therapeutics, Inc.
2024
Mutual Termination Agreement (Collaboration) by and between Checkpoint Therapeutics, Inc. and TG Therapeutics, Inc. dated September 30, 2023
Termination Agreements
Checkpoint Therapeutics, Inc.
2024
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2024
Form of Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2024
Form of Placement Agent Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2024
Form of Securities Purchase Agreement, dated as of January 27, 2024, by and between Checkpoint Therapeutics, Inc. and the Purchaser
Purchase Agreements
Checkpoint Therapeutics, Inc.
2024
Form of Series A/B Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Placement Agent Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Inducement Letter Agreement, dated as of October 2, 2023, by and between Checkpoint Therapeutics, Inc. and the Holder
Checkpoint Therapeutics, Inc.
2023
Amended and Restated Non-Employee Directors Compensation Plan
Compensation Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Series A/B Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Placement Agent Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Securities Purchase Agreement, dated as of July 28, 2023, by and between Checkpoint Therapeutics, Inc. and the Purchasers
Purchase Agreements
Checkpoint Therapeutics, Inc.
2023
Checkpoint Therapeutics, Inc. Amended and Restated 2015 Incentive Plan
Bonus & Incentive Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Series A/B Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Placement Agent Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Securities Purchase Agreement, dated as of May 23, 2023, by and between Checkpoint Therapeutics, Inc. and the Purchaser
Purchase Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Series A/B Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Placement Agent Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Securities Purchase Agreement, dated as of March 30, 2023, by and between Checkpoint Therapeutics, Inc. and the Purchasers
Purchase Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2023
Description of Securities of Checkpoint Therapeutics, Inc
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2023
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2023
Form of Series A/B Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Form of Placement Agent Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2023
Securities Purchase Agreement, dated as of February 20, 2023, by and between Checkpoint Therapeutics, Inc. and the Purchaser
Purchase Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2023
Form of Pre-Funded Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2022
Form of Series A/B Common Stock Purchase Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
2022
Form of Placement Agent Warrant
Warrant Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2022
Securities Purchase Agreement, dated as of December 14, 2022, by and between Checkpoint Therapeutics, Inc. and the Purchaser
Purchase Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2022
Amendment to Checkpoint Therapeutics, Inc. Amended and Restated 2015 Incentive Plan
Bonus & Incentive Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
2022
Description of Securities of Checkpoint Therapeutics, Inc
Checkpoint Therapeutics, Inc.
2022
Description of Securities of Checkpoint Therapeutics, Inc
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2021
Amendment No. 5, dated September 24, 2020, to the Executive Employment Agreement dated October 13, 2015, by and between Checkpoint Therapeutics, Inc. and James F. Oliviero III
Employment Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2020
Master Services Agreement between Samsung Biologics Co., Ltd. and Checkpoint Therapeutics, Inc., effective November 8, 2017
Services Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2020
Underwriting Agreement, entered into by and between Checkpoint Therapeutics, Inc. and H.C. Wainwright & Co., LLC, on September 17, 2020
Underwriting Agreements
Checkpoint Therapeutics, Inc.
2020
Amendment to Checkpoint Therapeutics, Inc. Amended and Restated 2015 Incentive Plan
Bonus & Incentive Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
2020
Description of Securities of Checkpoint Therapeutics, Inc
Checkpoint Therapeutics, Inc.
2020
Underwriting Agreement, entered into by Checkpoint Therapeutics, Inc. on November 20, 2019, with National Securities Corporation
Underwriting Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2019
Amendment No. 4, dated October 7, 2019, to the Executive Employment Agreement dated October 13, 2015, by and between Checkpoint Therapeutics, Inc. and James F. Oliviero III
Employment Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2019
Amended and Restated Collaboration Agreement by and between Checkpoint Therapeutics, Inc. and TG Therapeutics, Inc. dated June 19, 2019
Collaboration Agreements
Checkpoint Therapeutics, Inc.
2019
Collaboration Agreement by and between Adimab, LLC and Checkpoint Therapeutics, Inc., dated January 22, 2019
Collaboration Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
DE
2019
Certificate of Amendment of Amended and Restated Certificate of Incorporation of Checkpoint Therapeutics, Inc., dated June 14, 2018
Checkpoint Therapeutics, Inc.
Biotechnology
2018
Amendment No. 3, dated January 30, 2018, to the Executive Employment Agreement dated October 13, 2015, by and between Checkpoint Therapeutics, Inc. and James F. Oliviero III
Employment Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2018
Extension dated December 29, 2017, to Option Agreement by and between Fortress Biotech, Inc. and TG Therapeutics, Inc., dated March 17, 2015 (assigned to Checkpoint Therapeutics,...
Assignment Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
2018
Underwriting Agreement, entered into by Checkpoint Therapeutics, Inc. on March 8, 2018, with National Securities Corporation
Underwriting Agreements
Checkpoint Therapeutics, Inc.
2018
First Amendment to Amended and Restated Founders Agreement
Checkpoint Therapeutics, Inc.
Biotechnology
2017
CHECKPOINTTHERAPEUTICS, INC. AMENDEDAND RESTATED 2015 INCENTIVEPLAN ARTICLE1 PURPOSE
Checkpoint Therapeutics, Inc.
Biotechnology
DE
2017
AMENDED& RESTATED CHECKPOINT THERAPEUTICS, INC. NON-EMPLOYEEDIRECTORS COMPENSATION PLAN
Compensation Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
2017
SECOND AMENDMENT TO SUBLICENSE AGREEMENT
Checkpoint Therapeutics, Inc.
2017
SECOND AMENDMENT TO LICENSE AGREEMENT(Amendment # 2)
License Agreements
Checkpoint Therapeutics, Inc.
2017
Amendment 2 to Exclusive License Agreementbetween Checkpoint Therapeutics, Inc. and Dana-FarberCancer Institute, Inc.
License Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
2017
Amendment 3 to Exclusive License Agreementbetween Checkpoint Therapeutics, Inc. and Dana-FarberCancer Institute, Inc.
License Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
2017
FIRST AMENDMENT TO LICENSE AGREEMENT
License Agreements
Checkpoint Therapeutics, Inc.
2017
SECOND AMENDMENT TO EXECUTIVE EMPLOYMENTAGREEMENT
Checkpoint Therapeutics, Inc.
2017
BOARD ADVISORY SERVICES AGREEMENT
Services Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
DE
2017
EXTENSION OF OPTION AGREEMENT
Checkpoint Therapeutics, Inc.
Biotechnology
2017
FIRST AMENDMENT TO LICENSE AGREEMENT
License Agreements
Checkpoint Therapeutics, Inc.
2017
FIRST AMENDMENT TO SUBLICENSE AGREEMENT
Checkpoint Therapeutics, Inc.
2017
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Checkpoint Therapeutics, Inc.
Biotechnology
NY
2016
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Checkpoint Therapeutics, Inc.
2016